Logo-ijbsm
Submitted: 16 Oct 2022
Accepted: 25 Dec 2022
ePublished: 29 Dec 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Int J Basic Sci Med. 2022;7: 166-172.
doi: 10.34172/ijbsm.2022.29
  Abstract View: 327
  PDF Download: 160

Original Article

Correlation of CD40 and DPP-4 Concentration With Corrected TIMI Frame Count in Patients With Coronary Slow Flow

Sepideh Elyasi 1 ORCID logo, Jamal Shamsara 2 ORCID logo, Mostafa Dastani 3, Maedeh Sadoughi 1, Fatemeh Jafari 1, Mahdi Akbarzadeh 1, Amir Hooshang Mohammadpour 1,2*

1 Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
2 Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
3 Cardiovascular Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
*Corresponding Author: Correspondence to Amir Hooshang Mohammadpour, Email: , Email: MohamadpoorAH@mums.ac.ir

Abstract

Introduction: Microvascular and endothelial disorders play a significant role in the pathophysiology of coronary slow flow phenomenon (CSFP). However, according to previous studies, the etiology of CSFP is not completely understood. As CD40 and dipeptidyl peptidase-4 (DPP-4) are reported to play an important role in atherosclerosis process as well as microvascular and the endothelial dysfunction, this study evaluated the role of these two biomarkers in the pathophysiology of CSFP.

Methods: One-hundred twenty-nine volunteers who were candidates for angiography and fulfilled the inclusion criteria were selected, including 29 patients with coronary artery diseases (CADs) which had less than 50% stenosis (CAD+,<50%) and without CSF, 22 CAD+patients which had 50-90% stenosis (CAD+, 50%-90%) without CSF, 16 CAD+patients with CSF, 22 patients with CSF without stenosis in their arteries, and 40 healthy individuals as controls. The serum levels of CD40 and DPP-4 were measured by an enzyme-linked immunosorbent assay kit.

Results: There was no significant correlation between the serum concentration of CD40 and the thrombosis in myocardial infarction (TIMI) frame count (P=0.571). However, the serum concentration of CD40 in CAD+patients with CSF was significantly higher than the values in patients without CSF (P=0.022). Moreover, the concentration of DPP-4 in different coronary vessels did not exhibit any significant relation with TIMI score (P=0.763).

Conclusion: In the present study, no significant correlation was found between the serum concentrations of CD40 and DPP-4 and the mean corrected TIMI frame count (CTFC). Accordingly, further studies with larger population sizes are needed to investigate the correlation between CD40 and DPP-4 serum levels and CSFP.

Keywords: DPP-4, CD40, TIMI frame, Coronary slow flow

Please cite this article as follows: Elyasi S, Shamsara J, Dastani M, Sadoughi M, Jafari F, Akbarzadeh M, et al. Correlation of CD40 and DPP-4 concentration with corrected TIMI frame count in patients with coronary slow flow. Int J Basic Sci Med. 2022;7(4):166-172. doi:10.34172/ijbsm.2022.29.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 328

Your browser does not support the canvas element.


PDF Download: 160

Your browser does not support the canvas element.